ICCC Annual EBITDA
-$5.75 M
-$6.09 M-1779.23%
31 December 2023
Summary:
As of January 20, 2025, ICCC annual earnings before interest, taxes, depreciation & amortization is -$5.75 million, with the most recent change of -$6.09 million (-1779.23%) on December 31, 2023. During the last 3 years, it has fallen by -$7.48 million (-432.70%). ICCC annual EBITDA is now -313.01% below its all-time high of $2.70 million, reached on December 31, 2021.ICCC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICCC Quarterly EBITDA
$108.10 K
+$825.00 K+115.08%
30 September 2024
Summary:
As of January 20, 2025, ICCC quarterly earnings before interest, taxes, depreciation & amortization is $108.10 thousand, with the most recent change of +$825.00 thousand (+115.08%) on September 30, 2024. Over the past year, it has dropped by -$268.60 thousand (-71.30%). ICCC quarterly EBITDA is now -91.08% below its all-time high of $1.21 million, reached on March 31, 2022.ICCC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICCC TTM EBITDA
-$530.80 K
+$211.50 K+28.49%
30 September 2024
Summary:
As of January 20, 2025, ICCC TTM earnings before interest, taxes, depreciation & amortization is -$530.80 thousand, with the most recent change of +$211.50 thousand (+28.49%) on September 30, 2024. Over the past year, it has increased by +$99.40 thousand (+15.77%). ICCC TTM EBITDA is now -114.54% below its all-time high of $3.65 million, reached on March 31, 2022.ICCC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICCC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1779.2% | -71.3% | +15.8% |
| 3 y3 years | -432.7% | -71.3% | +15.8% |
| 5 y5 years | -6602.3% | -71.3% | +15.8% |
ICCC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -313.0% | at low | -91.1% | +106.9% | -114.5% | +83.6% |
| 5 y | 5-year | -313.0% | at low | -91.1% | +106.9% | -114.5% | +83.6% |
| alltime | all time | -313.0% | at low | -91.1% | +106.9% | -114.5% | +83.6% |
ImmuCell EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $108.10 K(-115.1%) | -$530.80 K(-28.5%) |
| June 2024 | - | -$716.90 K(-290.3%) | -$742.30 K(+17.8%) |
| Mar 2024 | - | $376.70 K(-226.1%) | -$630.20 K(-75.5%) |
| Dec 2023 | -$5.75 M(-1779.2%) | -$298.70 K(+188.9%) | -$2.57 M(-20.5%) |
| Sept 2023 | - | -$103.40 K(-82.9%) | -$3.24 M(+5.6%) |
| June 2023 | - | -$604.80 K(-61.4%) | -$3.07 M(+26.4%) |
| Mar 2023 | - | -$1.57 M(+62.7%) | -$2.43 M(-789.4%) |
| Dec 2022 | $342.30 K(-87.3%) | -$962.70 K(-1503.4%) | $351.90 K(-82.9%) |
| Sept 2022 | - | $68.60 K(+97.7%) | $2.06 M(-27.6%) |
| June 2022 | - | $34.70 K(-97.1%) | $2.84 M(-22.1%) |
| Mar 2022 | - | $1.21 M(+62.5%) | $3.65 M(+35.5%) |
| Dec 2021 | $2.70 M(+56.2%) | $745.40 K(-12.6%) | $2.69 M(-4.9%) |
| Sept 2021 | - | $852.50 K(+1.4%) | $2.83 M(+21.4%) |
| June 2021 | - | $840.90 K(+228.7%) | $2.34 M(+69.4%) |
| Mar 2021 | - | $255.80 K(-71.1%) | $1.38 M(-20.2%) |
| Dec 2020 | $1.73 M(+20.7%) | $884.70 K(+150.1%) | $1.73 M(+45.2%) |
| Sept 2020 | - | $353.80 K(-405.8%) | $1.19 M(+17.2%) |
| June 2020 | - | -$115.70 K(-119.1%) | $1.02 M(-15.4%) |
| Mar 2020 | - | $604.90 K(+74.5%) | $1.20 M(-16.2%) |
| Dec 2019 | $1.43 M(+1519.7%) | $346.70 K(+93.3%) | $1.43 M(+95.8%) |
| Sept 2019 | - | $179.40 K(+158.1%) | $731.20 K(-7.3%) |
| June 2019 | - | $69.50 K(-91.7%) | $788.50 K(-3.2%) |
| Mar 2019 | - | $836.20 K(-336.3%) | $814.20 K(+821.0%) |
| Dec 2018 | $88.40 K(-87.1%) | -$353.90 K(-249.5%) | $88.40 K(-70.0%) |
| Sept 2018 | - | $236.70 K(+148.6%) | $294.20 K(-240.0%) |
| June 2018 | - | $95.20 K(-13.8%) | -$210.20 K(-40.1%) |
| Mar 2018 | - | $110.40 K(-174.5%) | -$351.20 K(-151.3%) |
| Dec 2017 | $684.50 K(-60.3%) | -$148.10 K(-44.7%) | $684.50 K(-40.9%) |
| Sept 2017 | - | -$267.70 K(+484.5%) | $1.16 M(-31.6%) |
| June 2017 | - | -$45.80 K(-104.0%) | $1.69 M(-14.8%) |
| Mar 2017 | - | $1.15 M(+252.6%) | $1.98 M(+15.2%) |
| Dec 2016 | $1.72 M(-35.6%) | $325.00 K(+22.2%) | $1.72 M(-14.5%) |
| Sept 2016 | - | $266.00 K(+7.7%) | $2.01 M(-19.8%) |
| June 2016 | - | $247.00 K(-72.1%) | $2.51 M(-3.9%) |
| Mar 2016 | - | $884.30 K(+43.2%) | $2.61 M(-2.2%) |
| Dec 2015 | $2.67 M(+963.7%) | $617.60 K(-19.0%) | $2.67 M(+12.6%) |
| Sept 2015 | - | $762.20 K(+118.3%) | $2.37 M(+34.9%) |
| June 2015 | - | $349.20 K(-63.0%) | $1.76 M(+65.0%) |
| Mar 2015 | - | $944.10 K(+196.8%) | $1.07 M(+324.3%) |
| Dec 2014 | $251.30 K(-63.5%) | $318.10 K(+114.5%) | $251.30 K(-238.4%) |
| Sept 2014 | - | $148.30 K(-143.1%) | -$181.60 K(+31.0%) |
| June 2014 | - | -$344.30 K(-366.5%) | -$138.60 K(-141.7%) |
| Mar 2014 | - | $129.20 K(-212.5%) | $332.60 K(-51.7%) |
| Dec 2013 | $689.20 K(+2.9%) | -$114.80 K(-160.0%) | $689.20 K(-24.0%) |
| Sept 2013 | - | $191.30 K(+50.7%) | $906.80 K(+23.4%) |
| June 2013 | - | $126.90 K(-73.9%) | $734.70 K(-3.5%) |
| Mar 2013 | - | $485.80 K(+372.6%) | $761.60 K(+13.7%) |
| Dec 2012 | $669.90 K(-440.2%) | $102.80 K(+435.4%) | $669.90 K(-3.9%) |
| Sept 2012 | - | $19.20 K(-87.5%) | $697.00 K(+19.3%) |
| June 2012 | - | $153.80 K(-61.0%) | $584.10 K(+472.1%) |
| Mar 2012 | - | $394.10 K(+203.4%) | $102.10 K(-151.9%) |
| Dec 2011 | -$196.90 K(-18.7%) | $129.90 K(-238.6%) | -$196.70 K(-52.5%) |
| Sept 2011 | - | -$93.70 K(-71.5%) | -$413.80 K(-26.6%) |
| June 2011 | - | -$328.20 K(-444.4%) | -$564.10 K(+217.4%) |
| Mar 2011 | - | $95.30 K(-209.3%) | -$177.70 K(-23.6%) |
| Dec 2010 | -$242.30 K(+5809.8%) | -$87.20 K(-64.3%) | -$232.70 K(+101.3%) |
| Sept 2010 | - | -$244.00 K(-519.2%) | -$115.60 K(-155.5%) |
| June 2010 | - | $58.20 K(+44.4%) | $208.30 K(-433.3%) |
| Mar 2010 | - | $40.30 K(+34.8%) | -$62.50 K(-15.0%) |
| Dec 2009 | -$4100.00(-99.5%) | $29.90 K(-62.6%) | -$73.50 K(-75.0%) |
| Sept 2009 | - | $79.90 K(-137.6%) | -$293.80 K(-64.4%) |
| June 2009 | - | -$212.60 K(-825.6%) | -$826.00 K(-9.0%) |
| Mar 2009 | - | $29.30 K(-115.4%) | -$908.10 K(+18.2%) |
| Dec 2008 | -$768.50 K(-146.3%) | -$190.40 K(-57.9%) | -$768.50 K(+84.0%) |
| Sept 2008 | - | -$452.30 K(+53.5%) | -$417.70 K(-141.9%) |
| June 2008 | - | -$294.70 K(-274.5%) | $997.30 K(-21.8%) |
| Mar 2008 | - | $168.90 K(+5.3%) | $1.28 M(-23.2%) |
| Dec 2007 | $1.66 M(+58.3%) | $160.40 K(-83.3%) | $1.66 M(+2.0%) |
| Sept 2007 | - | $962.70 K(-6042.6%) | $1.63 M(+61.9%) |
| June 2007 | - | -$16.20 K(-102.9%) | $1.01 M(-10.3%) |
| Mar 2007 | - | $554.10 K(+332.6%) | $1.12 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | $1.05 M(-33.7%) | $128.10 K(-62.3%) | $1.15 M(-20.6%) |
| Sept 2006 | - | $339.70 K(+243.5%) | $1.45 M(+1.1%) |
| June 2006 | - | $98.90 K(-83.2%) | $1.44 M(-10.1%) |
| Mar 2006 | - | $587.80 K(+37.6%) | $1.60 M(+1.2%) |
| Dec 2005 | $1.58 M(+296.1%) | $427.10 K(+31.7%) | $1.58 M(+29.9%) |
| Sept 2005 | - | $324.30 K(+24.3%) | $1.22 M(+29.5%) |
| June 2005 | - | $260.80 K(-54.2%) | $940.30 K(+49.4%) |
| Mar 2005 | - | $569.50 K(+798.3%) | $629.50 K(+57.7%) |
| Dec 2004 | $399.30 K(-331.1%) | $63.40 K(+36.1%) | $399.30 K(+113.5%) |
| Sept 2004 | - | $46.60 K(-193.2%) | $187.00 K(+41.5%) |
| June 2004 | - | -$50.00 K(-114.7%) | $132.20 K(+303.0%) |
| Mar 2004 | - | $339.30 K(-327.9%) | $32.80 K(-119.0%) |
| Dec 2003 | -$172.80 K(-122.4%) | -$148.90 K(+1715.9%) | -$172.80 K(-161.5%) |
| Sept 2003 | - | -$8200.00(-94.5%) | $281.10 K(-26.6%) |
| June 2003 | - | -$149.40 K(-211.7%) | $382.80 K(-31.4%) |
| Mar 2003 | - | $133.70 K(-56.2%) | $558.40 K(-27.5%) |
| Dec 2002 | $769.90 K(-9.2%) | $305.00 K(+226.2%) | $769.90 K(-17.5%) |
| Sept 2002 | - | $93.50 K(+256.9%) | $933.70 K(+16.2%) |
| June 2002 | - | $26.20 K(-92.4%) | $803.60 K(-18.0%) |
| Mar 2002 | - | $345.20 K(-26.4%) | $980.40 K(+15.7%) |
| Dec 2001 | $847.60 K(+55.1%) | $468.80 K(-1380.9%) | $847.70 K(+20.1%) |
| Sept 2001 | - | -$36.60 K(-118.0%) | $705.70 K(+3.9%) |
| June 2001 | - | $203.00 K(-4.5%) | $679.10 K(+28.9%) |
| Mar 2001 | - | $212.50 K(-35.0%) | $527.00 K(-3.6%) |
| Dec 2000 | $546.50 K(-23.7%) | $326.80 K(-617.1%) | $546.50 K(+65.5%) |
| Sept 2000 | - | -$63.20 K(-224.2%) | $330.30 K(-40.2%) |
| June 2000 | - | $50.90 K(-78.1%) | $552.70 K(-8.2%) |
| Mar 2000 | - | $232.00 K(+109.8%) | $601.80 K(-10.2%) |
| Dec 1999 | $716.50 K(+616.5%) | $110.60 K(-30.5%) | $669.80 K(+19.8%) |
| Sept 1999 | - | $159.20 K(+59.2%) | $559.20 K(+39.8%) |
| June 1999 | - | $100.00 K(-66.7%) | $400.00 K(0.0%) |
| Mar 1999 | - | $300.00 K(>+9900.0%) | $400.00 K(+100.0%) |
| Dec 1998 | $100.00 K(-72.0%) | $0.00(0.0%) | $200.00 K(-64.1%) |
| Sept 1998 | - | $0.00(-100.0%) | $556.70 K(0.0%) |
| June 1998 | - | $100.00 K(0.0%) | $556.70 K(+116.9%) |
| Mar 1998 | - | $100.00 K(-72.0%) | $256.70 K(-28.0%) |
| Dec 1997 | $356.70 K(>+9900.0%) | $356.70 K(>+9900.0%) | $356.70 K(-10.8%) |
| Sept 1997 | - | $0.00(-100.0%) | $400.00 K(+100.0%) |
| June 1997 | - | -$200.00 K(-200.0%) | $200.00 K(0.0%) |
| Mar 1997 | - | $200.00 K(-50.0%) | $200.00 K(>+9900.0%) |
| Dec 1996 | $0.00(-100.0%) | $400.00 K(-300.0%) | $0.00(-100.0%) |
| Sept 1996 | - | -$200.00 K(0.0%) | -$300.00 K(+50.0%) |
| June 1996 | - | -$200.00 K(<-9900.0%) | -$200.00 K(+100.0%) |
| Mar 1996 | - | $0.00(-100.0%) | -$100.00 K(-200.0%) |
| Dec 1995 | $200.00 K(-300.0%) | $100.00 K(-200.0%) | $100.00 K(-200.0%) |
| Sept 1995 | - | -$100.00 K(0.0%) | -$100.00 K(-200.0%) |
| June 1995 | - | -$100.00 K(-150.0%) | $100.00 K(-66.7%) |
| Mar 1995 | - | $200.00 K(-300.0%) | $300.00 K(+50.0%) |
| Dec 1994 | -$100.00 K(<-9900.0%) | -$100.00 K(-200.0%) | $200.00 K(0.0%) |
| Sept 1994 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| June 1994 | - | $100.00 K(0.0%) | $100.00 K(>+9900.0%) |
| Mar 1994 | - | $100.00 K(-200.0%) | $0.00(-100.0%) |
| Dec 1993 | $0.00(-100.0%) | -$100.00 K(<-9900.0%) | -$100.00 K(0.0%) |
| Sept 1993 | - | $0.00(0.0%) | -$100.00 K(-50.0%) |
| June 1993 | - | $0.00(0.0%) | -$200.00 K(+100.0%) |
| Mar 1993 | - | $0.00(-100.0%) | -$100.00 K(-50.0%) |
| Dec 1992 | -$200.00 K(-84.6%) | -$100.00 K(0.0%) | -$200.00 K(-33.3%) |
| Sept 1992 | - | -$100.00 K(-200.0%) | -$300.00 K(-57.1%) |
| June 1992 | - | $100.00 K(-200.0%) | -$700.00 K(-36.4%) |
| Mar 1992 | - | -$100.00 K(-50.0%) | -$1.10 M(-26.7%) |
| Dec 1991 | -$1.30 M(+225.0%) | -$200.00 K(-60.0%) | -$1.50 M(+36.4%) |
| Sept 1991 | - | -$500.00 K(+66.7%) | -$1.10 M(+22.2%) |
| June 1991 | - | -$300.00 K(-40.0%) | -$900.00 K(+28.6%) |
| Mar 1991 | - | -$500.00 K(-350.0%) | -$700.00 K(+40.0%) |
| Dec 1990 | -$400.00 K(-50.0%) | $200.00 K(-166.7%) | -$500.00 K(-44.4%) |
| Sept 1990 | - | -$300.00 K(+200.0%) | -$900.00 K(+50.0%) |
| June 1990 | - | -$100.00 K(-66.7%) | -$600.00 K(-45.5%) |
| Mar 1990 | - | -$300.00 K(+50.0%) | -$1.10 M(+1000.0%) |
| Dec 1989 | -$800.00 K | -$200.00 K(<-9900.0%) | -$100.00 K(-200.0%) |
| Sept 1989 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| June 1989 | - | -$600.00 K(-185.7%) | $100.00 K(-85.7%) |
| Mar 1989 | - | $700.00 K | $700.00 K |
FAQ
- What is ImmuCell annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ImmuCell?
- What is ImmuCell annual EBITDA year-on-year change?
- What is ImmuCell quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ImmuCell?
- What is ImmuCell quarterly EBITDA year-on-year change?
- What is ImmuCell TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ImmuCell?
- What is ImmuCell TTM EBITDA year-on-year change?
What is ImmuCell annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ICCC is -$5.75 M
What is the all time high annual EBITDA for ImmuCell?
ImmuCell all-time high annual earnings before interest, taxes, depreciation & amortization is $2.70 M
What is ImmuCell annual EBITDA year-on-year change?
Over the past year, ICCC annual earnings before interest, taxes, depreciation & amortization has changed by -$6.09 M (-1779.23%)
What is ImmuCell quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ICCC is $108.10 K
What is the all time high quarterly EBITDA for ImmuCell?
ImmuCell all-time high quarterly earnings before interest, taxes, depreciation & amortization is $1.21 M
What is ImmuCell quarterly EBITDA year-on-year change?
Over the past year, ICCC quarterly earnings before interest, taxes, depreciation & amortization has changed by -$268.60 K (-71.30%)
What is ImmuCell TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ICCC is -$530.80 K
What is the all time high TTM EBITDA for ImmuCell?
ImmuCell all-time high TTM earnings before interest, taxes, depreciation & amortization is $3.65 M
What is ImmuCell TTM EBITDA year-on-year change?
Over the past year, ICCC TTM earnings before interest, taxes, depreciation & amortization has changed by +$99.40 K (+15.77%)